Internationally Recognised Contract Toxicology Research Laboratory purchased Debra

15 March 2003

LabLogic is pleased to announce that MPI Research, an internationally recognised contract toxicology research laboratory based in Mattawan, Michigan, recently purchased the Debra LIMS for their ADME studies.

“The acquisition of Debra allows us to be more responsive to our sponsors” said Mary M. Sherman, PhD, Director of ADME. “The features that we find invaluable are:

Ability to customize the protocol design

Electronic in-life data collection

Direct interface to instruments

21 CFR Part 11 compliance

Adding the protocol and data organized into one location facilitates supervisor review and study monitoring. Overall, the system is well thought out, allowing for fast and accurate experimental set-up, data collection and report generation.”

Richard Brown, Managing Director of LabLogic, said, “Contract Research Organisations have long benefited from using Debra to enhance the speed and accuracy of their data collection. These time savings give them competitive advantage and help produce data of the highest quality for their sponsors, many of whom also use Debra. We are delighted to have MPI Research join our growing list of users.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, animal health, and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world.